Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Journey Medical (DERM) over the last 5 years, with Q2 2025 value amounting to $60000.0.

  • Journey Medical's Tax Provisions changed N/A to $60000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $281000.0, marking a year-over-year change of. This contributed to the annual value of $61000.0 for FY2024, which is 7239.82% down from last year.
  • Journey Medical's Tax Provisions amounted to $60000.0 in Q2 2025.
  • Journey Medical's 5-year Tax Provisions high stood at $8.3 million for Q4 2021, and its period low was -$3.4 million during Q2 2021.
  • Its 4-year average for Tax Provisions is $179818.2, with a median of $60000.0 in 2025.
  • As far as peak fluctuations go, Journey Medical's Tax Provisions plummeted by 1477391.3% in 2021, and later skyrocketed by 86923.08% in 2023.
  • Journey Medical's Tax Provisions (Quarter) stood at $8.3 million in 2021, then crashed by 99.84% to $13000.0 in 2022, then skyrocketed by 869.23% to $126000.0 in 2023, then tumbled by 52.38% to $60000.0 in 2025.
  • Its Tax Provisions was $60000.0 in Q2 2025, compared to $126000.0 in Q4 2023 and $95000.0 in Q3 2023.